Companies In the News
Authors:
Date:
PRNewswire: March 21, 2017 – LEXINGTON, MA, U.S.A. – Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has received a key patent from the European Union.
“This new patent…
Authors:
Date:
Business Wire: March 20, 2017 – HEIDELBERG, Germany – Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced a strategic licensing agreement with AFT Pharmaceuticals (…
Authors:
Date:
Business Wire: March 15, 2017 – BEDFORD, MA, U.S.A. – Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapies for diseases and conditions of the eye, today announced positive results of a patient…
Authors:
Date:
PRNewswire: March 14, 2017 – SAN DIEGO, CA, U.S.A. – OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that they have entered into a technology access program (TAP) agreement with Inhibrx, LP, a privately…
Authors:
Date:
PRNewswire: March 14, 2017 – LUND, Sweden – Bonesupport AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease, or related surgery, announces that it has extended the term of its U.S. distribution agreement with Zimmer…
Authors:
Date:
PRNewswire: March 14, 2017 – MOUNT OLIVE, NJ, U.S.A. – Flowonix Medical Inc. of New Jersey and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra® II programmable infusion system in the Australian Direct Drug Administration for Refractory Epilepsy (…
